Director/PDMR Shareholding

Summary by AI BETAClose X

On September 25, 2025, Genus PLC announced that CEO Jorgen Kokke exercised 7,649 nil-cost options granted on May 2, 2023. To cover income tax and social security liabilities, Kokke sold 3,450 ordinary shares on the London Stock Exchange at a price of 2,331.99p per share. Following the transaction, Kokke retained 4,199 ordinary shares. The exercised options were over ordinary shares in Genus.

Disclaimer*

Companies

Genus (GNS)
UK 100